ERBB2 and lip and oral cavity carcinoma: Further, H2Mab-19 strongly reacted with endogenous HER2 in HO-1-u-1 cells (oral cancer) and only weakly reacted with other oral cancer cell lines, Ca9-22, HSC-2, and SAS (Fig. 1A).